Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00065351
Status:
COMPLETED
Last Update Posted:
2019-11-12
First Post:
2003-07-21
Brief Title:
Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
Sponsor:
Organization:
Celgene